Results 151 to 160 of about 1,535,680 (331)

Antibody formation in dysgammaglobulinemia. [PDF]

Journal of Clinical Investigation, 1966
Gerald J. Gleich, John H. Vaughan, Jonathan W. Uhr, H. A. Swedlund   +3 more
openaire   +3 more sources

A COMPARISON OF CUTANEOUS SENSITIZATION AND ANTIBODY FORMATION IN RABBITS IMMUNIZED BY INTRAVENOUS OR INTRADERMAL INJECTIONS OF INDIFFERENT OR HEMOLYTIC STREPTOCOCCI AND PNEUMOCOCCI [PDF]

, 1941
D. Murray Angevine
openalex   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source

Spatial and temporal changes in the distribution of proteoglycans during avian neural crest development [PDF]

, 1991
In this study, we describe the distribution of various classes of proteoglycans and their potential matrix ligand, hyaluronan, during neural crest development in the trunk region of the chicken embryo.
Bronner-Fraser, Marianne, Domingo, Carmen, Krotoski, Danuta, Lallier, Thomas, Perris, Roberto, Sorrell, Michael   +5 more
core  

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Effect of Tocilizumab Treatment on Seroconversion in Hyperinflammation Secondary to Covid 19

Acta Medica Alanya
Aim:During the ongoing COVID-19 pandemic, the management of hyperinflammation, a serious symptom that occurs secondary to the disease, has emerged as a major challenge. Tocilizumab, an immunosuppressive drug, offers a potential solution.
Nilgün Işıksaçan, Hakan Koçoğlu, Ezgi Şahin, Deniz Yılmaz, Faruk Karandere, Felemez Arslan   +5 more
doaj   +1 more source

Studies on the Effect of Interferon on the Formation of Antibody in Mouse Spleen Cells [PDF]

, 1967
Scott Mazzur, Barbara Ellsworth, Kurt Paucker   +2 more
openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. [PDF]

J Intern Med, 2022
Brun MK, Goll GL, Jørgensen KK, Sexton J, Gehin JE, Sandanger Ø, Olsen IC, Klaasen RA, Warren DJ, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA, Syversen SW.   +14 more
europepmc   +1 more source

ANTIBODY FORMATION [PDF]

, 1963
Jonathan W. Uhr, Martin S. Finkelstein
openalex   +1 more source